In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome
- PMID: 1383571
- PMCID: PMC240183
- DOI: 10.1128/JVI.66.11.6806-6812.1992
In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome
Abstract
Reverse transcriptases contain a highly conserved YXDD amino acid motif believed to be important in enzyme function. The second amino acid is not strictly conserved, with a methionine, valine or alanine occupying the second position in reverse transcriptases from various retroviruses and retroelements. Recently, a 3.5-A (0.35-nm) resolution electron density map of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase positioned the YMDD motif within an antiparallel beta-hairpin structure which forms a portion of its catalytic site. To further explore the role of methionine of the conserved YMDD motif in HIV-1 reverse transcriptase function, we have substituted methionine with a valine, alanine, serine, glycine, or proline, reflecting in some cases sequence motifs of other related reverse transcriptases. Wild-type and mutant enzymes were expressed in Escherichia coli, partially purified by phosphocellulose chromatography, and assayed for the capacity to polymerize TTP by using a homopolymeric template [poly(rA)] with either a DNA [oligo(dT)] or an RNA [oligo(U)] primer. With a poly(rA).oligo(dT) template-primer, reverse transcriptases with the methionine replaced by valine (YVDD), serine (YSDD), or alanine (YADD) were 70 to 100% as active as the wild type, while those with the glycine substitution (YGDD) were approximately 5 to 10% as active. A proline substitution (YPDD) completely inactivated the enzyme. With a poly(rA).oligo(U) template-primer, only the activity of mutants with YVDD was similar to that of the wild type, while mutants with YADD and YSDD were approximately 5 to 10% as active as the wild-type enzyme. The reverse transcriptases with the YGDD and YPDD mutations demonstrated no activity above background. Proviruses containing the reverse transcriptase with the valine mutation (YVDD) produced viruses with infectivities similar to that of the wild type, as determined by measurement of p24 antigen in culture supernatants and visual inspection of syncytium formation. In contrast, proviruses with reverse transcriptases containing the YADD and YSDD mutations were less infectious than wild-type virus. These results point to the critical role of methionine of the YMDD motif in the activity of HIV-1 reverse transcriptase and subsequent replication potential of the virus.
Similar articles
-
YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.J Virol. 2001 Jul;75(14):6321-8. doi: 10.1128/JVI.75.14.6321-6328.2001. J Virol. 2001. PMID: 11413298 Free PMC article.
-
Loss of polymerase activity due to Tyr to Phe substitution in the YMDD motif of human immunodeficiency virus type-1 reverse transcriptase is compensated by Met to Val substitution within the same motif.Biochemistry. 1998 Jul 7;37(27):9630-40. doi: 10.1021/bi980549z. Biochemistry. 1998. PMID: 9657675
-
Enzymatic activity of poliovirus RNA polymerases with mutations at the tyrosine residue of the conserved YGDD motif: isolation and characterization of polioviruses containing RNA polymerases with FGDD and MGDD sequences.J Virol. 1993 Jan;67(1):373-81. doi: 10.1128/JVI.67.1.373-381.1993. J Virol. 1993. PMID: 8380083 Free PMC article.
-
Retrovirus reverse transcriptases containing a modified YXDD motif.Antivir Chem Chemother. 2005;16(3):169-82. doi: 10.1177/095632020501600303. Antivir Chem Chemother. 2005. PMID: 16004080 Review.
-
Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases.Prog Nucleic Acid Res Mol Biol. 2002;71:91-147. doi: 10.1016/s0079-6603(02)71042-8. Prog Nucleic Acid Res Mol Biol. 2002. PMID: 12102562 Review.
Cited by
-
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20).J Virol. 2004 May;78(9):4628-37. doi: 10.1128/jvi.78.9.4628-4637.2004. J Virol. 2004. PMID: 15078945 Free PMC article.
-
Interaction of reverse transcriptase (RT) mutations conferring resistance to lamivudine and etravirine: effects on fitness and RT activity of human immunodeficiency virus type 1.J Virol. 2011 Nov;85(21):11309-14. doi: 10.1128/JVI.05578-11. Epub 2011 Aug 17. J Virol. 2011. PMID: 21849432 Free PMC article.
-
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases.Sci Rep. 2014 Sep 18;4:6409. doi: 10.1038/srep06409. Sci Rep. 2014. PMID: 25230987 Free PMC article.
-
The M184V substitution in human immunodeficiency virus type 1 reverse transcriptase delays the development of resistance to amprenavir and efavirenz in subtype B and C clinical isolates.Antimicrob Agents Chemother. 2003 Jul;47(7):2376-9. doi: 10.1128/AAC.47.7.2376-2379.2003. Antimicrob Agents Chemother. 2003. PMID: 12821504 Free PMC article.
-
Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.J Virol. 2007 Mar;81(6):3012-7. doi: 10.1128/JVI.02257-06. Epub 2006 Dec 20. J Virol. 2007. PMID: 17182677 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources